Law360 (March 19, 2018, 6:42 PM EDT) — Allergan and the Native American tribe that acquired patents for its Restasis medication urged the Federal Circuit on Friday to stop the Patent Trial and Appeal Board’s review of the patents, days after generic-drug makers ripped their claims of immunity as …
